HBK Investments’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

HBK Investments’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,004,042	Closed	-$96.2M	–	559
2020 Q1	$96.2M	Buy	2,004,042 +1,922,677	+2,363%	+$89.4M	4.94%	9
2019 Q4	$3.82M	Buy	+81,365	New	+$3.6M	0.04%	333

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

HBK Investments's RARX Position: Q2 2020 in Review

HBK Investments sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 2,004,042 shares — an estimated $96.2M sold.

HBK Investments first reported a position in RARX in Q4 2019 and held it in 2 quarters. The position peaked at $96.2M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

HBK Investments reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
HBK Investments sold 2,004,042 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $96.2M.
HBK Investments first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
HBK Investments's Ra Pharmaceuticals, Inc. Common Stock position peaked at $96.2M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on HBK Investments's 13F filing for Q2 2020, filed 14 Aug 2020.